Answer
Nucala (mepolizumab) is indicated as add-on therapy with intranasal corticosteroids for adults with severe chronic rhinosinusitis with nasal polyps when systemic corticosteroids and/or surgery do not provide adequate disease control.
Sources for this answer
- Nucala 100 mg solution for injection in pre-filled penGlaxoSmithKline UK · emc · SmPC §4.1 Therapeutic Indications · Version 11Document updated
Sources checked